GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is currently emerging as a significant focus in healthcare investigation, largely due to its impressive impact on controlling conditions such as type 2 diabetes and excess body fat. New trials have revealed that beyond glucose management